AgonOx, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors (NCT05902520) | AgonOx, Inc. | 2023-06-19 |
Track AgonOx, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.